Raquel Mendoza‐Tesarik

682 total citations
23 papers, 444 citations indexed

About

Raquel Mendoza‐Tesarik is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Raquel Mendoza‐Tesarik has authored 23 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Reproductive Medicine, 16 papers in Public Health, Environmental and Occupational Health and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Raquel Mendoza‐Tesarik's work include Ovarian function and disorders (16 papers), Reproductive Biology and Fertility (15 papers) and Reproductive System and Pregnancy (5 papers). Raquel Mendoza‐Tesarik is often cited by papers focused on Ovarian function and disorders (16 papers), Reproductive Biology and Fertility (15 papers) and Reproductive System and Pregnancy (5 papers). Raquel Mendoza‐Tesarik collaborates with scholars based in Spain, Italy and France. Raquel Mendoza‐Tesarik's co-authors include Jan Tesařík, Nicolás Mendoza, Carmen Mendoza, A. Hazout, C. Mendoza, Signe Altmäe, Francesco Cucinelli, Agnese Maria Chiara Rapisarda, Mónica Olivares and J. Fonollá and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and American Journal of Obstetrics and Gynecology.

In The Last Decade

Raquel Mendoza‐Tesarik

19 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raquel Mendoza‐Tesarik Spain 11 343 282 100 83 60 23 444
Nicolò Ubaldi Italy 10 363 1.1× 379 1.3× 283 2.8× 62 0.7× 84 1.4× 23 585
Funda Göde Türkiye 13 318 0.9× 312 1.1× 115 1.1× 31 0.4× 67 1.1× 26 503
Alicia Marzal Spain 6 193 0.6× 204 0.7× 103 1.0× 71 0.9× 53 0.9× 12 286
Xiu-e Lu China 6 245 0.7× 227 0.8× 77 0.8× 43 0.5× 51 0.8× 10 335
A. Gala France 10 240 0.7× 231 0.8× 97 1.0× 96 1.2× 80 1.3× 32 379
Yundong Mao China 15 489 1.4× 359 1.3× 142 1.4× 112 1.3× 98 1.6× 45 630
A Lobascio Italy 11 136 0.4× 216 0.8× 107 1.1× 84 1.0× 164 2.7× 17 461
Ri‐Cheng Chian China 9 191 0.6× 241 0.9× 56 0.6× 47 0.6× 107 1.8× 19 355
Yasuhisa Munakata Japan 11 150 0.4× 249 0.9× 48 0.5× 38 0.5× 135 2.3× 18 340

Countries citing papers authored by Raquel Mendoza‐Tesarik

Since Specialization
Citations

This map shows the geographic impact of Raquel Mendoza‐Tesarik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raquel Mendoza‐Tesarik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raquel Mendoza‐Tesarik more than expected).

Fields of papers citing papers by Raquel Mendoza‐Tesarik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raquel Mendoza‐Tesarik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raquel Mendoza‐Tesarik. The network helps show where Raquel Mendoza‐Tesarik may publish in the future.

Co-authorship network of co-authors of Raquel Mendoza‐Tesarik

This figure shows the co-authorship network connecting the top 25 collaborators of Raquel Mendoza‐Tesarik. A scholar is included among the top collaborators of Raquel Mendoza‐Tesarik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raquel Mendoza‐Tesarik. Raquel Mendoza‐Tesarik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tesařík, Jan & Raquel Mendoza‐Tesarik. (2023). Mitochondria in Human Fertility and Infertility. International Journal of Molecular Sciences. 24(10). 8950–8950. 16 indexed citations
2.
Vitale, Salvatore Giovanni, Marco Palumbo, Agnese Maria Chiara Rapisarda, et al.. (2022). Use of pentoxifylline during ovarian stimulation to improve oocyte and embryo quality: A retrospective study.. Journal of Gynecology Obstetrics and Human Reproduction. 51(6). 102398–102398. 5 indexed citations
3.
Tesařík, Jan & Raquel Mendoza‐Tesarik. (2022). Patient-tailored reproductive health care. SHILAP Revista de lepidopterología. 4. 917159–917159. 1 indexed citations
4.
Tesařík, Jan & Raquel Mendoza‐Tesarik. (2022). Cyclic Adenosine Monophosphate: A Central Player in Gamete Development and Fertilization, and Possible Target for Infertility Therapies. International Journal of Molecular Sciences. 23(23). 15068–15068. 3 indexed citations
5.
Tesařík, Jan & Raquel Mendoza‐Tesarik. (2022). Molecular Clues to Understanding Causes of Human-Assisted Reproduction Treatment Failures and Possible Treatment Options. International Journal of Molecular Sciences. 23(18). 10357–10357. 2 indexed citations
6.
Molina, Nerea M., Julio Plaza‐Díaz, Ramiro Vilchez‐Vargas, et al.. (2021). Assessing the testicular sperm microbiome: a low-biomass site with abundant contamination. Reproductive BioMedicine Online. 43(3). 523–531. 34 indexed citations
7.
Tesařík, Jan, et al.. (2021). Double HCG trigger improves recovery of oocytes in women with a paucifollicular response to ovarian stimulation: A pilot study. International Journal of Gynecology & Obstetrics. 157(1). 149–153. 3 indexed citations
8.
Tesařík, Jan & Raquel Mendoza‐Tesarik. (2020). New Criteria for the Use of Growth Hormone in the Treatment of Female Infertility: Minireview and a Case Series. 9(3). 1–4. 3 indexed citations
9.
Tesařík, Jan, et al.. (2020). The Effect of GH Administration on Oocyte and Zygote Quality in Young Women With Repeated Implantation Failure After IVF. Frontiers in Endocrinology. 11. 519572–519572. 19 indexed citations
10.
Tesařík, Jan, et al.. (2020). Luteal Phase in Assisted Reproductive Technology. Frontiers in Reproductive Health. 2. 595183–595183. 9 indexed citations
11.
Mendoza, Nicolás, Plácido Llaneza, Raquel Mendoza‐Tesarik, et al.. (2019). Comparison of the effect of two combinations of myo-inositol and D -chiro-inositol in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial. Gynecological Endocrinology. 35(8). 695–700. 23 indexed citations
12.
Mendoza‐Tesarik, Raquel, et al.. (2019). GnRH agonist treatment of luteal phase deficiency in HCG-triggered IVF cycles: a matched case-control study. Reproductive BioMedicine Online. 39(2). 225–230. 10 indexed citations
13.
Mendoza, Nicolás, et al.. (2019). High dose of d-chiro-inositol improves oocyte quality in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial. Gynecological Endocrinology. 36(5). 398–401. 15 indexed citations
14.
15.
16.
Altmäe, Signe, Raquel Mendoza‐Tesarik, Carmen Mendoza, et al.. (2017). Effect of Growth Hormone on Uterine Receptivity in Women With Repeated Implantation Failure in an Oocyte Donation Program: A Randomized Controlled Trial. Journal of the Endocrine Society. 2(1). 96–105. 52 indexed citations
17.
18.
Tesařík, Jan, Raquel Mendoza‐Tesarik, & Nicolás Mendoza. (2016). Virtual ultrasonographic hysteroscopy followed by conventional operative hysteroscopy, enabling pregnancy. American Journal of Obstetrics and Gynecology. 216(2). 188.e1–188.e1. 13 indexed citations
19.
Tesařík, Jan, A. Hazout, Raquel Mendoza‐Tesarik, Nicolás Mendoza, & C. Mendoza. (2006). Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles. Human Reproduction. 21(10). 2572–2579. 97 indexed citations
20.
Tesařík, Jan, Raquel Mendoza‐Tesarik, & Carmen Mendoza. (2006). Sperm nuclear DNA damage: update on the mechanism, diagnosis and treatment. Reproductive BioMedicine Online. 12(6). 715–721. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicolò Ubaldi Breakdown of academic impact, for papers by Funda Göde Breakdown of academic impact, for papers by Alicia Marzal Breakdown of academic impact, for papers by Xiu-e Lu Breakdown of academic impact, for papers by A. Gala Breakdown of academic impact, for papers by Yundong Mao Breakdown of academic impact, for papers by A Lobascio Breakdown of academic impact, for papers by Ri‐Cheng Chian Breakdown of academic impact, for papers by Yasuhisa Munakata
Rankless by CCL
2026